Advanced Drug Formulation Design to Optimize Therapeutic Outcomes (inbunden)
Fler böcker inom
Format
Inbunden (Hardback)
Språk
Engelska
Antal sidor
536
Utgivningsdatum
2007-09-01
Förlag
CRC Press Inc
Illustrationer
47 Halftones, black and white; 27 Tables, black and white; 180 Illustrations, black and white
Dimensioner
236 x 161 x 31 mm
Vikt
849 g
Antal komponenter
1
ISBN
9781420043877
Advanced Drug Formulation Design to Optimize Therapeutic Outcomes (inbunden)

Advanced Drug Formulation Design to Optimize Therapeutic Outcomes

Inbunden Engelska, 2007-09-01
1749
Skickas inom 7-10 vardagar.
Gratis frakt inom Sverige över 159 kr för privatpersoner.
This title demonstrates how advanced formulation designs and delivery technologies can be used to improve drug efficacy and treatment outcomes in particular therapeutic categories or disease states. It discusses nanoparticle systems for cancer treatments, and also presents cutting edge immono-regulation agents for transplantation and the local targeting of drugs, especially poorly water soluble drugs to provide enhanced therapeutic outcomes. In addition, this title highlights areas of therapy showing the most promise for improvement in clinical outcomes via advanced formulation design.
Visa hela texten

Passar bra ihop

  1. Advanced Drug Formulation Design to Optimize Therapeutic Outcomes
  2. +
  3. Formulating Poorly Water Soluble Drugs

De som köpt den här boken har ofta också köpt Formulating Poorly Water Soluble Drugs av Robert O Williams Iii, Alan B Watts, Dave A Miller (inbunden).

Köp båda 2 för 4448 kr

Kundrecensioner

Har du läst boken? Sätt ditt betyg »

Fler böcker av författarna

Innehållsförteckning

Short Contents Part 1: Infectious Diseases. Introduction. Pulmonary Infections. Oral Infections. Systemic Infections. Ophthalmic Infections. Part 2: Oncology. Introduction. Targeted Nanoparticle Systems for Cancer Therapy. Systemic Delivery of Anti-cancer Agents. Cancer and the Blood Brain Barrier. Part 3: Transplantation. Immunosuppression for Transplantation Patients. Systemic Delivery of Immunosuppressants. Targeted Delivery of Immunosuppresants. Part 4: Other Therapies. Trans-Mucosal Delivery. CNS Diseases. Endocrinological Diseases